22-Jul-2014 - Botox maker Allergan announced sales and earnings per share growth above the high end of its expectations, but it will cut 1,500 jobs, or about 13% of its workforce as it continues to avoid a $54bn hostile takeover bid from Valeant Pharmaceuticals.
21-Jul-2014 - India-based Glenmark Pharmaceuticals has announced plans to set up a new oral solid dosage manufacturing facility in North Carolina.
15-Jul-2014 - Biocatalyst developer Codexis says its new platform licensing deal with GSK is a model with which it can approach other Big Pharma firms.
11-Jul-2014 - Pfizer says 100 workers at an Irish facility will now keep their jobs due to an unpredicted increase in production volumes of off-patent drugs.
10-Jul-2014 - Actavis says it is closing facilities in St. Louis, Missouri affecting 190 jobs a week after completing the $28bn (€21bn) acquisition of Forest Laboratories.
10-Jul-2014 - G-CON says a multi-million dollar investment by Pfizer could hasten the “paradigm shift” in pharma manufacturing towards flexible cleanroom technology and portable facility design.
08-Jul-2014 - Finished dosage form and API manufacturer Xellia has acquired a US plant from Fresenius Kabi in a deal it says enhances supply chain security.
08-Jul-2014 - M+W says a lack of synergies with its engineering and construction business drove the decision to sell its automation divison to ATS for €255m ($348m).
01-Jul-2014 - With its purchase of Veropharm for up to $495m, Abbott is looking to tap into one of the largest Russian manufacturers of pharmaceuticals.
30-Jun-2014 - Chinese pharma is looking for added value and “famous brands” from its processing providers, the tableting and packaging supplier Romaco has said.
25-Jun-2014 - The United States Food and Drug Administration (FDA) has announced it will consider products outside the nanoscale, up to 1,000 nanometres (nm), to involve nanotechnology and so be potentially liable for “particular examination.”
24-Jun-2014 - BioReliance and its parent company SAFC say they are working on viral-resistant cell lines that will prevent contamination in bioreactors.
23-Jun-2014 - The US National Institutes of Health (NIH) has launched a 3D Print Exchange which will turn data submitted by the public into files for printing 3D models.
17-Jun-2014 - Fette Compacting America claims its new tablet press technology can accelerate the production of large drug batches.
12-Jun-2014 - Teva could halve its manufacturing network as part of its $2bn-a-year efficiency programme says CFO Eyal Desheh, with most cuts hitting its core generics business.
10-Jun-2014 - Malvern Instruments will buy GE Healthcare’s MicroCal business in a deal that adds protein analysis and formulation development tech to its expanding drug industry offering.
09-Jun-2014 - J&J says it collaborated with Novartis and GSK to install wind turbines in Cork, Ireland to substantially reduce electricity costs at its local manufacturing plants.
05-Jun-2014 - The Puerto Rico Industrial Development Company (PRIDCO) says Actavis’ investment at two facilities is evidence of continued pharma growth, despite a number of recent closures on the island.
05-Jun-2014 - The days of testing for leaks in blister packs with traditional blue dye are numbered at Pfizer, which has replaced the method with high-tech scans.
03-Jun-2014 - Tax breaks and the promise of preferential treament for locally made drugs were key to attracting Pfizer to the UAE says DuBiotech.
29-May-2014 - Hikma Pharmaceuticals says it is evaluating Ben Venue’s manufacturing facility as an option in its $300m (€220m) acquisition of Bedford Laboratories.
28-May-2014 - As the number of drug approvals declined between 2012 and 2013 by more than 30%, the value of new therapeutic agent approvals seems to indicate a stronger year than initially thought.
27-May-2014 - RNA-based drug developer Sarepta Therapeutics has agreed to acquire a manufacturing facility on 26 acres of land in Massachusetts for $25m.
21-May-2014 - Both Fresenius Kabi and Abbott have extended their operations further in the Latin American market with new acquisitions that signal growth in the region.
21-May-2014 - Manufacturing powerhouse Roche is doubling down on its small molecule manufacturing with investments of $134.6m in two facilities in Basel, Switzerland.
Pharmaceutical companies are rushing to respond to shortened deadlines from China’s Food and Drug Administration (CFDA) for...
GSK is confident it can meet Flulaval production targets ahead of this winter’s flu season despite ongoing...
Representatives for GSK have targeted struggling graduates and unpaid interns as volunteers for clinical trials, saying the...
Drug raw materials suppliers have not recognised their potential value to biopharmaceutical customers according to Roche which...
Teva could halve its manufacturing network as part of its $2bn-a-year efficiency programme says CFO Eyal Desheh,...